Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P95
Near historical high
vs 2Y Ago
3.3x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 45.01% |
| Q3 2025 | -29.90% |
| Q2 2025 | 34.70% |
| Q1 2025 | -24.61% |
| Q4 2024 | 1.81% |
| Q3 2024 | -13.28% |
| Q2 2024 | -18.03% |
| Q1 2024 | -9.42% |
| Q4 2023 | 13.60% |
| Q3 2023 | -12.04% |
| Q2 2023 | 14.81% |
| Q1 2023 | 8.43% |
| Q4 2022 | -19.30% |
| Q3 2022 | -13.23% |
| Q2 2022 | 32.75% |
| Q1 2022 | -38.99% |
| Q4 2021 | -34.77% |
| Q3 2021 | -29.34% |
| Q2 2021 | 26.90% |
| Q1 2021 | -13.55% |
| Q4 2020 | -40.85% |
| Q3 2020 | 14.26% |
| Q2 2020 | -27.18% |
| Q1 2020 | -5.13% |
| Q4 2019 | 1.25% |
| Q3 2019 | 5.61% |
| Q2 2019 | -2.32% |
| Q1 2019 | 6.73% |
| Q4 2018 | -3.68% |
| Q3 2018 | -7.04% |
| Q2 2018 | -13.61% |
| Q1 2018 | 10.45% |
| Q4 2017 | 52.38% |
| Q3 2017 | -45.66% |
| Q2 2017 | 47.47% |
| Q1 2017 | 2.89% |
| Q4 2016 | -25.98% |
| Q3 2016 | 14.63% |
| Q2 2016 | -15.53% |
| Q1 2016 | 6.74% |